Disclosed is an altered, soluble form of the FLT polypeptide being capable of binding to VEGF and thereby exerting an inhibitory effect thereon, the polypeptide comprising five or fewer complete immunoglobulin-like domains, together with pharmaceutical compositions comprising the polypeptide, and various uses thereof.
申请公布号
WO9533050(A1)
申请公布日期
1995.12.07
申请号
WO1995GB01213
申请日期
1995.05.26
申请人
LYNXVALE LIMITED;CHARNOCK-JONES, DAVID, STEPHEN;BOOCOCK, CHRISTINE, ANNE;SHARKEY, ANDREW, MARK;SMITH, STEPHEN, KEVIN
发明人
CHARNOCK-JONES, DAVID, STEPHEN;BOOCOCK, CHRISTINE, ANNE;SHARKEY, ANDREW, MARK;SMITH, STEPHEN, KEVIN